Hyloris Developments SA   Report issue

For profit Phase 3
Founded: Liege Belgium (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2018
NCT03532776
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hyloris Developments SA